Page results
-
UCLH today marks International Clinical Trials Day, which this year coincides with the National Institute for Health Research (NIHR) campaign encouraging everyone to ‘Be Part of Research.’
-
If your doctor has referred you for a blood test, please book your phlebotomy (blood test) appointment online in advance.
-
Emma, our support and information specialist, gives tips to overcome loneliness.
-
UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).
-
This information has been developed by the welfare and benefits team based in the Macmillan Support and Information Service. It outlines the most common benefits available.
-
A summary of a twitter chat hosted by the Macmillan Support and Information Service on cancer-related fatigue with advice about to manage it.
-
Information about having a gadolinium-based contrast agent for MRI examinations while breastfeeding.
-
An evaluation of temporary changes to children and young people’s services in North Central London (NCL) in the autumn and winter of 2020/21 has been published.
-
HTD Outpatients offers a wide range of clinics for Chagas disease, Infectious diseases, Leishmaniasis, Leprosy , Malaria , Microbiology, Neglected tropical diseases, Parasitology
-
After delivering more than 80,000 vaccines, the vaccination centre at The Francis Crick Institute closes its doors today (13 August 2021) with the last vaccination taking place at 7pm.
File results
-
FOI/2023/0542 - Pulmonary rehabilitation (PR)
-
FOI/2023/0550 - Varicose veins referrals, treatment and wait time
-
FOI/2023/0553 - Maternity complaints by ethnicity
-
FOI/2023/0559 - Patients admitted to hospital with dental distress
-
FOI/2023/0560 - Digital maternity training platform
-
FOI/2023/0561 - Birthrate Plus
-
FOI/2023/0563 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0566 - Structure chart for IM &T, Business Intelligence, Informatics
-
FOI/2023/0569 - Treatment for Ruxolitinib